Sept. 26, 2017
Public Citizen Hosts Panel Discussion About the Effect of Trump’s Leaked Executive Order on Affordable Medicines at Home and Abroad
WHAT: Panel discussion about the affordability of medicines in the U.S. and abroad, in the wake of a recently leaked draft of an executive order to be issued by President Donald Trump. Trump’s order shifts the blame of U.S. prices on other, often impoverished countries while doing little to make therapies more accessible in the U.S. It also would give pharmaceutical companies more monopoly power in the U.S. and overseas. The executive order increases Washington, D.C., pressure on developing countries to make medications less accessible, which could lead to the deaths of many, while missing a historic opportunity to make lifesaving treatments affordable across the globe.
This U.S. government pressure caused a scandal last year when an American official was reported to have warned Colombia that reducing the price of a patented cancer therapy could jeopardize Obama administration support for its peace process.
Public Citizen is hosting a panel and community conversation to discuss questions such as: How is the Trump administration connecting its “America First” economic policies to its pharmaceutical working group and major trade disputes? Which policies may succeed, and which are distractions? How can we focus on the necessary reforms to make medications accessible all?
WHEN: 3:30-5:30 p.m. EDT Wednesday, Sept. 27
WHO: Peter Maybarduk, director, Public Citizen’s Access to Medicines program
Dr. Francisco Rossi, director, IFARMA Fundacion in Colombia
Alejandra Alayza, advocacy and campaign manager, Oxfam in Peru
LIVESTREAM: The event will be streamed live on Public Citizen’s Facebook page: https://www.facebook.com/publiccitizen/.